GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $25,790,000 | -28.7% | 595,473 | -9.2% | 4.19% | +28.8% |
| Q3 2020 | $36,154,000 | +5.6% | 655,676 | +20.9% | 3.25% | +18.9% |
| Q2 2020 | $34,229,000 | -45.2% | 542,200 | -54.1% | 2.74% | -55.7% |
| Q1 2019 | $62,457,000 | +28.9% | 1,180,000 | 0.0% | 6.18% | +1.0% |
| Q4 2018 | $48,439,000 | -31.9% | 1,180,000 | -25.0% | 6.12% | -37.9% |
| Q2 2018 | $71,081,000 | -99.8% | 1,572,600 | +111.8% | 9.85% | +85.0% |
| Q1 2018 | $35,854,000,000 | +90724.8% | 742,331 | -26.0% | 5.32% | -21.0% |
| Q4 2017 | $39,476,000 | +126.8% | 1,003,205 | +79.0% | 6.74% | +98.9% |
| Q3 2017 | $17,403,000 | +149.1% | 560,498 | +119.5% | 3.39% | +170.7% |
| Q2 2017 | $6,985,000 | -36.8% | 255,400 | -14.9% | 1.25% | -43.0% |
| Q1 2017 | $11,055,000 | -23.5% | 300,000 | -70.0% | 2.20% | -26.0% |
| Q4 2016 | $14,450,000 | – | 1,000,000 | – | 2.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |